HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,592 | +77.6% | 6,400 | +100.0% | 0.00% | – |
| Q2 2023 | $3,712 | +75.6% | 3,200 | +128.6% | 0.00% | – |
| Q1 2023 | $2,114 | -39.6% | 1,400 | 0.0% | 0.00% | – |
| Q4 2022 | $3,500 | -41.7% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $6,000 | +50.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -50.0% | 1,400 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $8,000 | -38.5% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | -13.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -31.8% | 1,400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $22,000 | -4.3% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $23,000 | -23.3% | 1,400 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $30,000 | +42.9% | 1,400 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $21,000 | 0.0% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $21,000 | +31.2% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |